Thalamic DBS triggers periods of behavioral stillness coinciding with low-frequency activity in the EEG, similar to absence epilepsy. by Michelle J. Redinbaugh (13029044)

DataSheet_1_Extreme marine heatwaves and cold-spells events in the Southern North Sea: classifications, patterns, and trends.pdf by Bayoumy Mohamed (17004717)

“…We then estimated the difference between their annual mean values and the possible relationship with the large-scale climate modes of natural sea surface temperature (SST) and atmospheric variability using satellite SST data. …”

Cumulative release of Mn²⁺ from MnO NPs over 24 hr after incubation in PBS pH 7.4 (dotted line), 20 mM citrate buffer pH 6.5 (dashed line), and 20 mM citrate buffer pH 5... by Celia Martinez de la Torre (9396180)

“…<p>Controlled release curves are shown for MnO NPs generated with the following temperature profiles: a) 5 min at 300°C with 20°C/min ramp, b) 5 min at 300°C with 10°C/min ramp, c) 15 min at 300°C with 20°C/min ramp, d) 15 min at 300°C with 10°C/min ramp, and e) 30 min at 300°C with 10°C/min ramp. …”

EGCG and luteolin do not synergistically reduce WPMY-1 cell proliferation and viability. by Alana L. Gray (637670)

<i>In vitro</i> and <i>in vivo</i> properties of aminotriazines used in this study. by David J. Matson (625974)

Varying dose. by Brenda Lyn A. Gavina (15285185)

Image_3_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF by Ana Rita Vaz (6566963)

“…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1^G93A microglia. …”

Image_3_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF by Ana Rita Vaz (6566963)

“…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1^G93A microglia. …”

Image_1_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF by Ana Rita Vaz (6566963)

“…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1^G93A microglia. …”

Image_3_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF by Ana Rita Vaz (6566963)

“…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1^G93A microglia. …”

Image_2_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF by Ana Rita Vaz (6566963)

“…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1^G93A microglia. …”

Image_2_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF by Ana Rita Vaz (6566963)

“…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1^G93A microglia. …”

Data_Sheet_1_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.docx by Ana Rita Vaz (6566963)

“…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1^G93A microglia. …”

Data_Sheet_1_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.docx by Ana Rita Vaz (6566963)

“…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1^G93A microglia. …”

Image_2_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF by Ana Rita Vaz (6566963)

“…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1^G93A microglia. …”

Data_Sheet_1_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.docx by Ana Rita Vaz (6566963)

“…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1^G93A microglia. …”

Image_1_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF by Ana Rita Vaz (6566963)

“…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1^G93A microglia. …”

Image_1_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF by Ana Rita Vaz (6566963)

“…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1^G93A microglia. …”

Hypomethylation of the Intron 1 CpG island results in WT1 expression. by Gregory McCarty (708081)

Importance of HIF-1α and TET2/3 in CoCl₂-mediated induction of WT1 and WT1 lncRNA. by Gregory McCarty (708081)